What Researchers Did
Researchers investigated the efficacy of hyperbaric oxygen (HBO2) treatment in 10 patients diagnosed with central retinal artery occlusion (CRAO), administering 20 HBO2 sessions along with other medications and monitoring visual acuity.
What They Found
The study included 10 eyes from 10 patients. Average visual acuity significantly improved from LogMAR 3 before treatment to LogMAR 1.8 after treatment (P < 0.05). No patients developed neovascular glaucoma during the study period.
What This Means for Canadian Patients
This research suggests that hyperbaric oxygen treatment could be a beneficial option for Canadian patients experiencing central retinal artery occlusion, potentially improving their visual outcomes. Patients should discuss this treatment with their ophthalmologist, particularly if diagnosed in the acute or subacute phases.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A significant limitation of this study is its small sample size of only 10 patients, which restricts the generalizability of the findings.